Opus Genetics (IRD) EPS (Weighted Average and Diluted) Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -38.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.88% |
| Dec 31, 2025 | -28.55% |
| Sep 30, 2025 | -4.35% |
| Jun 30, 2025 | 21.70% |
| Mar 31, 2025 | 11.82% |
| Dec 31, 2024 | -91.80% |
| Sep 30, 2024 | -5.07% |
| Jun 30, 2024 | 16.75% |
| Mar 31, 2024 | 56.69% |
| Dec 31, 2023 | 61.47% |
| Sep 30, 2023 | 40.23% |
| Jun 30, 2023 | 17.67% |
| Mar 31, 2023 | 31.47% |
| Jun 30, 2021 | -63.03% |
| Dec 31, 2020 | -212.72% |
| Sep 30, 2020 | -102.06% |
| Jun 30, 2020 | -153.72% |
| Mar 31, 2020 | 1.49% |